The ESG Report – Cally Edgren on Forever Chemicals
State AG Pulse | AGs to Forever Chemicals Cos: We Want More Money and We Want It Now
PFAS in Focus: Forever-Engineering With Trent Stober, HDR - Reflections on Water Podcast
PFAS in Focus: Wastewater Utility Perspectives From Jay Hoskins, Metropolitan St. Louis Sewer District - Reflections on Water Podcast
PFAS in Focus: Show-Me Insights From Chris Wieberg, Missouri Department of Natural Resources - Reflections on Water Podcast
[Podcast] Catching Up on Canadian Environmental Regulation
PFAS: Increasing Regulations and Managing Legal Liability
PFAS Regulatory Update: EPA Issues Updated Drinking Water Health Advisories
Drinking Water on Tap: Money, Morality, and More with Tracy Mehan from the American Water Works Association - Reflections on Water Podcast
EPA Plan Changes PFAS Outlook For Companies, Regulators
2BInformed: Understanding the EPA’s New PFAS Strategic Roadmap and Upcoming PBT Regulations
2BInformed: Overview of PFAS and Related EPA Regulations; EPA’s New Chemical Program Under Amended TSCA
Starting 2BInformed: The Inaugural Episode of the Podcast Series, ‘2BInformed,’ with Baptist and Bertrand
The Great Green North: A Discussion on Canada’s Environmental Regulations
Forever Chemicals: What They are and What is being Done to Minimize Their Impact
What are PFAS and Why Should We Care?
Here are curated AG and federal regulatory news stories highlighting key areas in which state and federal regulators’ decisions are having an impact across the US: • Weighty Penalty for Bootleg GLP-1 Drug Sales - • 50 AGs...more
Manufacturers of all types of products have been using per- and polyfluoroalkyl substances (PFAS) for decades. From a manufacturing perspective, PFAS have several benefits, including resistance to grease, oil, water, heat and...more
From pharmaceuticals to cosmetics, preemption to expert preclusion, New York state and federal courts issued decisions in 2023, which further shaped the landscape in the medical and life sciences legal world. To prepare the...more
Hosted by American Conference Institute, the 28th Annual Conference on Drug & Medical Device Litigation returns for another exciting year with curated programming and networking opportunities with 400+ industry...more
Here are curated AG and federal regulatory news stories highlighting key areas in which state and federal regulators’ decisions are having an impact across the US: •FTC Seeks Public Input to Strengthen Collaboration with...more
The cosmetics industry is undergoing massive change, with the newly passed “Modernization of Cosmetics Regulation Act 2022”. At American Conference Institute’s 10th Annual Forum on Cosmetics & Personal Care Products join our...more
On May 27, 2022, Senate Health, Education, Labor, and Pensions (“HELP”) Committee leaders introduced the Food and Drug Administration Safety and Landmark Advancements Act of 2022 (“FDASLA Act of 2022”), which, if passed,...more
FDA Continues to Focus on Identifying and Controlling Trace Impurities in Drugs - On December 23, 2021, the U.S. Food and Drug Administration (“FDA”) alerted drug manufacturers that FDA was investigating the root cause of...more
When members of the U.S. House of Representatives and Senate were sworn into office in January 2019, Democrats took control of the House and its oversight agenda for the first time in eight years, 235-200 seats, and...more
Outlook for This Week in the Nation’s Capital - Appropriations. All signs are currently positive that the appropriations process will wrap up in time to meet the December 20 deadline....more
Outlook for This Week in the Nation's Capital - Congress. After some very contentious debate and a handful of defections, the House late last week passed the annual National Defense Authorization Act on a rare party line...more
Outlook for This Week in the Nation's Capital - Congress. The House and Senate have one week of legislative work remaining before they break for the Fourth of July recess period, and it looks to be quite busy. ...more